Lv4
738 积分 2023-08-08 加入
Finerenone in CKD from Estimands to Clinical Interpretability under Competing Risk
16天前
已关闭
Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists
16天前
已完结
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
16天前
已关闭
The nonsteroidal MR antagonist finerenone reverses Western diet-induced kidney disease by regulating mitochondrial and lipid metabolism and inflammation
16天前
已关闭
Effectiveness and safety of finerenone in IgA nephropathy patients
16天前
已完结
Effect of Finerenone on Morbidity and Mortality in CKD
16天前
已关闭
Finerenone ameliorates high-fat-induced myocardial lipotoxicity by suppressing ferroptosis through augmenting the system Xc-/GSH synthesis pathway
16天前
已关闭
Innovative therapeutics for renoprotection: Where we are
16天前
已完结
Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cells
3个月前
已完结
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
3个月前
已完结
皖公网安备34019202002308
